Floatz logo

Granisetron

Vomiting

University of Southern CaliforniaSmall moleculePhase 1Dormant
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Vomiting cohort.

Asset / SponsorPhaseRating
Phosphonic acid, P-[3-[[(2R,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]-
Rush University Medical Center
Phase 4A
Zofran
University of South Florida
Phase 4BBB
DEXAMETHASONE
Jun Zhu
Phase 4BB
Tropisetron
Jun Zhu
Phase 4BB
Olanzapine
Rush University Medical Center
Phase 3BB

View all 19 →

Same molecule, other indications

Granisetron is also rated in:

cancer of unknown primary siteDormant
BB
Indicative ·
71 / 100
View asset →
myofascial pain syndromeDormant
BB
Indicative ·
69 / 100
View asset →
temporomandibular joint disorderDormant
BB
Indicative ·
69 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →